Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ASSOCIATION OF COMMUNITY CANCER CENTERS Effective Practices in Bladder Cancer Care: MULTISPECIALTY CLINICS Multidisciplinary care in the form of multispecialty bladder cancer clinics, has been shown to improve disease assessment and treatment recommendations for patients with bladder cancer, and increase patient access to specialty treatment and coordinated care.1,2 While insufficient clinic …
ASSOCIATION OF COMMUNITY CANCER CENTERS Effective Practices in Bladder Cancer Care: MULTISPECIALTY CLINICS Multidisciplinary care in the form of multispecialty bladder cancer clinics, has been shown to improve disease assessment and treatment recommendations for patients with bladder cancer, and increase patient access to specialty treatment and coordinated care.1,2 While insufficient clinic …
ASSOCIATION OF COMMUNITY CANCER CENTERS Effective Practices in Bladder Cancer Care: ENGAGING PATIENTS IN THEIR CARE Goals-of-Care Conversations As with all cancers, a bladder cancer diagnosis can be scary and overwhelming for both patients and their caregivers. Compared to other cancer types, however, patient experience of bladder cancer care is especially poor.1 For people with …
Accelerated Approvals Reconsidered Blenrep (belantamab mafodotin-blmf) - GSK said Tuesday that following a request from FDA, it will withdraw its blood cancer drug from the U.S. market. The decision comes a little more than two years after the BCMA-directed antibody and microtubule inhibitor conjugate was granted an accelerated approval as 5th-line therapy for adult patients with relapsed …
Accelerated Approvals Reconsidered Blenrep (belantamab mafodotin-blmf) - GSK said Tuesday that following a request from FDA, it will withdraw its blood cancer drug from the U.S. market. The decision comes a little more than two years after the BCMA-directed antibody and microtubule inhibitor conjugate was granted an accelerated approval as 5th-line therapy for adult patients with relapsed …
Accelerated Approvals Reconsidered Blenrep (belantamab mafodotin-blmf) - GSK said Tuesday that following a request from FDA, it will withdraw its blood cancer drug from the U.S. market. The decision comes a little more than two years after the BCMA-directed antibody and microtubule inhibitor conjugate was granted an accelerated approval as 5th-line therapy for adult patients with relapsed …
December 13, 2022
Learn about the key policy changes finalized by the Centers for Medicare & Medicaid Services (CMS) in the CY 2023 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) final rules. Speakers will discuss how these reimbursement changes will impact oncology programs and practices starting January 1, 2023, and identify other legislative and regulatory updates …
PowerPoint Presentation Dec. 8, 2022 TxSCO Update Overview: Notable Updates 2 Federal • Prior Auth Proposed Rule • Lame Duck Expectations • Provider Cuts • HHS’ Policy Agenda for 2023 • Notable Reports • ASCO report on Prior Auth • Hospital Acquisitions Outside of Commuting Zones on the Rise State • Leadership Update • House Speaker • …
Accelerated Approvals Reconsidered Blenrep (belantamab mafodotin-blmf) - GSK said Tuesday that following a request from FDA, it will withdraw its blood cancer drug from the U.S. market. The decision comes a little more than two years after the BCMA-directed antibody and microtubule inhibitor conjugate was granted an accelerated approval as 5th-line therapy for adult patients with relapsed …
The NCCN closed out 2022 with a patient advocacy summit focused on sexual orientation and gender identity, highlighting the barriers that can prevent LGBTQ+ patients with cancer, as well as survivors, from accessing high-quality, equitable care.
Accelerated Approvals Reconsidered Blenrep (belantamab mafodotin-blmf) - GSK said Tuesday that following a request from FDA, it will withdraw its blood cancer drug from the U.S. market. The decision comes a little more than two years after the BCMA-directed antibody and microtubule inhibitor conjugate was granted an accelerated approval as 5th-line therapy for adult patients with relapsed …
Accelerated Approvals Reconsidered Blenrep (belantamab mafodotin-blmf) - GSK said Tuesday that following a request from FDA, it will withdraw its blood cancer drug from the U.S. market. The decision comes a little more than two years after the BCMA-directed antibody and microtubule inhibitor conjugate was granted an accelerated approval as 5th-line therapy for adult patients with relapsed …
November 28, 2022 The Honorable Charles Schumer Majority Leader United States Senate Washington, DC 20510 The Honorable Mitch McConnell Republican Leader United States Senate Washington, DC 20510 The Honorable Nancy Pelosi Speaker United States House of Representatives Washington, DC 20515 The Honorable Kevin McCarthy Republican …
December 11, 2022
Fulton Alley 600 Fulton Street New Orleans, LA 504.208.5569 In conjunction with the ASH Annual Meeting & Exposition—December 10-13—the Louisiana Oncology Society invites you to join local professionals for a casual evening of sipping and socializing at our complimentary meet and greet reception. Enjoy libations and hors d'oeuvres as you meet other oncology professionals in the local …
December 10, 2022
Ernest N. Morial Convention Center New Orleans, LA Register now for the 64th ASH Annual Meeting and Exposition, December 10-13 at the Ernest N. Morial Convention Center in New Orleans or attend virtually! Make sure to register by October 26 to receive the discounted registration rate. Some highlights at this year’s meeting include virtual meeting platform access for all in-person meeting …
December 9, 2022
Join the Rocky Mountain Oncology Society for an exciting evening of learning and networking at our Professional Development Workshop. Designed to support early career professionals, this complimentary workshop offers an opportunity to collaborate with clinicians in all stages of their career as they impart valuable pearls of wisdom about practicing outside the scope of academia. Plus, make new connections …
ACCC shares how Sanford Health introduced its own “precision medicine steward” through the development of a pilot Oncology Nurse Navigator, Genomics (ONNG) role, which has improved coordination of its biomarker testing program.
On November 10, 2022, ACCC President Dr. David R. Penberthy, MBA, held his third in a series of four Tech Talks, where invited subject matter experts and ACCC members discussed remote patient monitoring (RPM) in cancer care.
December 8, 2022
Join Us for this Exciting Virtual Educational Event Association of Community Cancer Centers (ACCC) is pleased to join with the American Psychosocial Oncology Society (APOS) and the Association of Oncology Social Work (AOSW) for a joint symposium on Zoom, Thursday, Dec. 8, from 1 to 3 PM EST. Mark your calendars and plan to attend! Learn More & Register Speakers: Stephan Courtwright, PhD Research …
Discover how Emily Smith, MD, addresses determinants of health in her practice and best practice recommendations for high quality care.